Quest Diagnostics Inc. (DGX) Insider Trading
Directors, officers and holders of more than 10% of DGX report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 330 transactions on file: 0 with code P, 8 with code S and 42 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 26, 2026 | PFEIFFER GARY M | Director | S Sale | 1,203 | $243.00 | $292,329 |
| Oct 21, 2026 | MAIN TIMOTHY L | Director | L Small Acquisition | 18 | $235.94 | $4,247 |
| Oct 21, 2026 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L Small Acquisition | 33 | $235.94 | $7,786 |
| Oct 21, 2026 | DELANEY MARK E | SVP & Chief Commercial Officer | L Small Acquisition | 25 | $235.94 | $5,899 |
| Oct 21, 2026 | SAMAD SAM | Executive Vice President & CFO | A Award | 90 | $235.94 | $21,235 |
| Oct 21, 2026 | Plewman Patrick | SVP for Diagnostic Services | L Small Acquisition | 41 | $235.94 | $9,674 |
| Oct 21, 2026 | Lassiter Wright III | Director | L Small Acquisition | 6 | $235.96 | $1,416 |
| Oct 21, 2026 | CARTER ROBERT B | Director | L Small Acquisition | 10 | $235.93 | $2,359 |
| Oct 21, 2026 | Gregg Vicky B | Director | A Award | 63 | $235.94 | $14,864 |
| Oct 1, 2026 | WENTWORTH TIMOTHY C | Director | A Award | 135 | Not measured | Not measured |
| Sep 1, 2026 | Davis J. E. | CEO and President | S Sale | 10,000 | $242.72 | $2,427,200 |
| Aug 28, 2026 | PREVOZNIK MICHAEL E | SVP & General Counsel | G Gift | 1,000 | Not measured | Not measured |
| Aug 28, 2026 | PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 16,010 | $242.88 | $3,888,437 |
| Aug 28, 2026 | PREVOZNIK MICHAEL E | SVP & General Counsel | M Exercise | 22,677 | $112.17 | $2,543,679 |
| Aug 28, 2026 | PREVOZNIK MICHAEL E | SVP & General Counsel | M Exercise | 22,677 | $112.17 | $2,543,679 |
| Aug 28, 2026 | PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 6,237 | $243.63 | $1,519,505 |
| Aug 28, 2026 | PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 430 | $244.51 | $105,141 |
| Jul 28, 2026 | DELANEY MARK E | SVP & Chief Commercial Officer | S Sale | 1,600 | $235.18 | $376,288 |
| Jul 22, 2026 | CARTER ROBERT B | Director | L Small Acquisition | 11 | $206.80 | $2,275 |
| Jul 22, 2026 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L Small Acquisition | 37 | $206.81 | $7,652 |
| Jul 22, 2026 | MAIN TIMOTHY L | Director | L Small Acquisition | 21 | $206.81 | $4,343 |
| Jul 22, 2026 | SAMAD SAM | Executive Vice President & CFO | A Award | 102 | $206.81 | $21,094 |
| Jul 22, 2026 | Lassiter Wright III | Director | L Small Acquisition | 6 | $206.81 | $1,241 |
| Jul 22, 2026 | DELANEY MARK E | SVP & Chief Commercial Officer | L Small Acquisition | 34 | $206.81 | $7,031 |
| Jul 22, 2026 | Plewman Patrick | SVP for Diagnostic Services | L Small Acquisition | 46 | $206.81 | $9,513 |
| Jul 22, 2026 | Gregg Vicky B | Director | A Award | 72 | $206.81 | $14,890 |
| Jul 1, 2026 | WENTWORTH TIMOTHY C | Director | A Award | 144 | Not measured | Not measured |
| Jun 4, 2026 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | S Sale | 8,147 | $200.00 | $1,629,400 |
| Jun 4, 2026 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | M Exercise | 4,827 | $121.81 | $587,953 |
| Jun 4, 2026 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | M Exercise | 4,827 | $121.81 | $587,953 |
| Jun 4, 2026 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | M Exercise | 3,320 | $127.72 | $424,047 |
| Jun 4, 2026 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | M Exercise | 3,320 | $127.72 | $424,047 |
| Jun 1, 2026 | Davis J. E. | CEO and President | S Sale | 10,000 | $194.14 | $1,941,400 |
| May 20, 2026 | Gregg Vicky B | Director | A Award | 1,142 | Not measured | Not measured |
| May 20, 2026 | MAIN TIMOTHY L | Director | A Award | 1,142 | Not measured | Not measured |
| May 20, 2026 | CARTER ROBERT B | Director | A Award | 1,142 | Not measured | Not measured |
| May 20, 2026 | Doi Tracey | Director | A Award | 1,142 | Not measured | Not measured |
| May 20, 2026 | RING TIMOTHY M | Director | A Award | 1,142 | Not measured | Not measured |
| May 20, 2026 | Lassiter Wright III | Director | A Award | 1,142 | Not measured | Not measured |
| May 20, 2026 | MORRISON DENISE M | Director | A Award | 1,142 | Not measured | Not measured |
| May 20, 2026 | PFEIFFER GARY M | Director | A Award | 1,142 | Not measured | Not measured |
| May 20, 2026 | WENTWORTH TIMOTHY C | Director | A Award | 1,142 | Not measured | Not measured |
| May 20, 2026 | Diaz Luis | Director | A Award | 1,142 | Not measured | Not measured |
| Apr 20, 2026 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L Small Acquisition | 39 | $194.70 | $7,593 |
| Apr 20, 2026 | DELANEY MARK E | SVP & Chief Commercial Officer | L Small Acquisition | 37 | $194.70 | $7,204 |
| Apr 20, 2026 | CARTER ROBERT B | Director | L Small Acquisition | 7 | $194.70 | $1,363 |
| Apr 20, 2026 | Lassiter Wright III | Director | L Small Acquisition | 6 | $194.70 | $1,168 |
| Apr 20, 2026 | Plewman Patrick | SVP for Diagnostic Services | L Small Acquisition | 49 | $194.70 | $9,540 |
| Apr 20, 2026 | SAMAD SAM | Executive Vice President & CFO | A Award | 108 | $194.70 | $21,027 |
| Apr 20, 2026 | Gregg Vicky B | Director | A Award | 68 | $194.70 | $13,239 |
The full Form 4 history is on the DGX company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.